Related by context. All words. (Click for frequent words.) 75 TELINTRA 75 Xanafide 72 elotuzumab 71 lumiliximab 71 Bezielle 71 gefitinib Iressa 71 MAGE A3 ASCI 70 visilizumab 70 riociguat 70 sorafenib Nexavar 70 Panzem R NCD 70 velafermin 70 oral prodrug 70 MGd 70 HBeAg positive patients 70 relapsed MM 70 docetaxel chemotherapy 70 SPRYCEL ® 70 pomalidomide 69 oxymorphone ER 69 lapatinib Tykerb 69 galiximab 69 erlotinib Tarceva ® 69 Doxil ® 69 demonstrated antitumor activity 69 dasatinib Sprycel 69 urocortin 2 69 thalidomide Thalomid 69 nucleoside analog 69 ocrelizumab 69 lenalidomide dexamethasone 69 mRCC 69 intravenous cyclophosphamide 69 teriflunomide 69 panitumumab Vectibix 69 cannabinor 69 YONDELIS 69 generation purine nucleoside 68 AEGR 68 CTAP# Capsules 68 TELCYTA 68 vidofludimus 68 lenalidomide Revlimid R 68 imatinib therapy 68 sitaxsentan 68 docetaxel Taxotere ® 68 Fibrillex TM 68 VELCADE melphalan 68 cilengitide 68 Vitaxin 68 PANVAC VF 68 Aflibercept 68 cetuximab Erbitux R 68 Symadex 68 ara C 68 alkylating agent 68 Quinamed 68 TBC# 68 calcineurin inhibitor 68 recurrent glioblastoma multiforme 68 CANCIDAS 68 apremilast 68 bosutinib 68 Plicera 68 Troxatyl 68 APTIVUS r 68 Tarceva TM 68 motesanib 68 bendamustine 68 liposomal amphotericin B 68 Nuvion 68 sargramostim 68 beta 1a 68 estramustine 68 samalizumab 68 investigational monoclonal antibody 68 HGS ETR2 68 PEG IFN 68 Archexin 68 Phase IIb trials 68 VEGF inhibitors 68 mycophenolate mofetil 67 docetaxel Taxotere 67 TLK# 67 Specifid 67 decitabine 67 leukemia ALL 67 leukemia AML 67 adriamycin 67 proteasome inhibitor 67 DEB# 67 receptor tyrosine kinase inhibitor 67 mapatumumab 67 CYT# potent vascular disrupting 67 refractory gout 67 vandetanib 67 imatinib Gleevec 67 dexamethasone Decadron 67 MYLOTARG 67 HuLuc# 67 neurologic progression 67 Epratuzumab 67 Traficet EN 67 Aptivus ® 67 BARACLUDE ® 67 immunomodulatory therapy 67 ribavirin RBV 67 dacetuzumab 67 dasatinib Sprycel ® 67 forodesine 67 HBeAg negative patients 67 palifermin 67 zanolimumab 67 pertuzumab 67 evaluating tivozanib 67 OHR/AVR# 67 Telcyta 67 pegylated liposomal doxorubicin PLD 67 HuMax CD4 67 tanespimycin 67 RhuDex TM 67 haematologic 67 antiangiogenic therapy 67 metastatic malignant 67 lupus nephritis 67 INCB# [001] 67 valopicitabine 67 axitinib 67 Poly ICLC 67 Xcellerated T Cells 67 gemcitabine Gemzar ® 67 Vidofludimus 67 Phase Ib clinical 67 phase IIb clinical 67 diarrhea predominant irritable 67 liposomal formulation 67 dexanabinol 67 Pimavanserin 67 receptor inhibitor 67 Reverset 67 BAY #-# 67 THR beta agonist 67 alemtuzumab Campath 67 IL# PE#QQR 67 cytopenias 67 antibody MAb 67 liposomal doxorubicin 67 AGILECT R 67 Kamada AAT 67 NS#/#A protease 67 Interferon alpha 67 trastuzumab Herceptin ® 67 mertansine 67 ELACYT 66 gemcitabine Gemzar 66 K ras mutations 66 pamidronate 66 Pegasys ® 66 bortezomib Velcade 66 rituximab Rituxan 66 GSK# [002] 66 Zorbtive TM 66 TYZEKA 66 Velcade bortezomib 66 CINTREDEKIN BESUDOTOX 66 Fludara ® 66 tramiprosate Alzhemed TM 66 Kepivance 66 acute GvHD 66 lomitapide 66 Zolinza 66 ZOLINZA 66 protease inhibitor PI 66 novel VDA molecule 66 UPLYSO 66 DAVANAT 66 nucleotide analog 66 lintuzumab 66 Arranon 66 SAR# [004] 66 HGS ETR1 66 Onconase 66 mycophenolate mofetil MMF 66 idarubicin 66 BENICAR HCT 66 Targretin 66 gemcitabine carboplatin 66 coadministration 66 EFAPROXYN 66 HuMax EGFr 66 PNP inhibitor 66 Amplimexon 66 ribavirin therapy 66 gemifloxacin 66 REMINYL ® 66 Phase #b/#a trial 66 huN# DM1 66 Apoptone 66 idiopathic thrombocytopenic purpura ITP 66 Neuvenge 66 intravesical therapy 66 midstage trials 66 CoFactor 66 imatinib Gleevec ® 66 imatinib mesylate Gleevec 66 grade cervical intraepithelial 66 Tasimelteon 66 GSK# [001] 66 caspofungin 66 #mg/m# [001] 66 Panzem R 66 renal toxicity 66 glufosfamide 66 refractory AML 66 lintuzumab SGN 66 SinuNase TM 66 baminercept 66 erlotinib Tarceva 66 neutropenia dehydration dyspnea 66 docetaxel Taxotere R 66 cisplatin gemcitabine 66 Tocosol Paclitaxel 66 temsirolimus 66 hypercalcemia 66 IRX 2 66 alvespimycin 66 evaluating REVLIMID 66 neratinib 66 Cloretazine ® 66 FUSILEV enhances 66 PEGylated interferon beta 1a 66 mitoxantrone plus 66 trastuzumab Herceptin R 66 chlorambucil 66 hepatic fibrosis 66 sunitinib malate 66 Alocrest 66 azacitidine 66 refractory chronic lymphocytic 66 Vidaza azacitidine 66 non metastatic osteosarcoma 66 selective modulator 66 mTOR inhibitors 66 octreotide 66 alfa 2a 66 ruxolitinib 66 Amgen Neulasta R 66 ONTAK 66 Cleviprex TM clevidipine 66 sorafenib tablets 66 diabetic neuropathic pain 66 PXD# 66 Tekamlo 66 Solorel TM 66 adecatumumab 66 Fludara 66 HCV RESPOND 2 66 TACI Ig 66 PSN# [002] 66 intermittent dosing 66 peginterferon alfa 66 uric acid lowering 66 paclitaxel Taxol 66 epithelial tumors 66 virologic failure 66 ACZ# 66 Telbivudine 66 cetuximab Erbitux ® 66 Pemetrexed 66 eritoran 66 tumor lysis syndrome 66 PSMA ADC 65 Dasatinib 65 Androxal TM 65 Asentar 65 rALLy 65 mGluR5 NAM 65 Tarceva erlotinib 65 elacytarabine 65 CYC# 65 2 methoxyestradiol 65 GHRH 65 polycythemia vera essential thrombocythemia 65 iniparib 65 cisplatin chemotherapy 65 tafamidis 65 leukemia CLL 65 EDEMA3 65 ixabepilone 65 pioglitazone HCl 65 Faslodex 65 PRT# 65 interferon ribavirin 65 inhaled liposomal ciprofloxacin 65 HGS# 65 tarenflurbil 65 CHOP chemotherapy 65 MKC# MT 65 LymphoStat B belimumab 65 gemtuzumab ozogamicin 65 omega interferon 65 CLORETAZINE TM VNP#M 65 AQ4N 65 pegylated liposomal doxorubicin 65 Xelox 65 Tesmilifene 65 vismodegib 65 Taxotere chemotherapy 65 Leukine ® 65 relapsed leukemia 65 Cannabinor 65 efaproxiral 65 CA9 SCAN 65 efalizumab 65 phase IIb study 65 alefacept 65 Seliciclib 65 ofatumumab HuMax CD# 65 Teriflunomide 65 SYN# 65 cediranib 65 tumors GIST 65 adalimumab Humira 65 Darusentan 65 preclinically 65 Triapine R 65 ProSavin 65 midstage clinical 65 anti leukemic 65 taxane chemotherapy 65 hypoxia activated prodrug 65 virus HCV protease inhibitor 65 S/GSK# 65 Phase #/#a trial 65 JAK inhibitor 65 assessing T DM1 65 humanised monoclonal antibody 65 posaconazole 65 etanercept Enbrel 65 pegylated interferon alpha 65 oral candidiasis 65 AMEVIVE 65 HBeAg negative chronic hepatitis 65 PEG SN# 65 interferon alfa 2b 65 CIMZIA TM 65 biologic DMARD 65 PEG PAL 65 terlipressin 65 RhuDex ® 65 CIMZIA ™ 65 VAPRISOL 65 ibandronate 65 CIMZIA TM certolizumab pegol 65 Romiplostim 65 Phenoptin 65 NEUVENGE 65 Phase #b/#a clinical 65 peginterferon alfa 2a Pegasys 65 Aplidin 65 Annamycin 65 rindopepimut 65 hematologic disorders 65 EOquin 65 heavily pretreated 65 MYCAMINE 65 plus prednisone 65 cardiotoxic 65 Viramidine 65 interferon alfa 65 PRTX 65 Dacogen decitabine 65 anthracycline therapy 65 canakinumab 65 GALNS 65 Ocrelizumab 65 6R BH4 65 orally dosed 65 plus prednisone prednisolone 65 ATL/TV# 65 salmeterol fluticasone 65 cangrelor 65 oblimersen 65 Gemzar ® 65 bardoxolone methyl 65 Marqibo TM 65 hyperphenylalaninemia HPA due 65 PROMACTA 65 orally administered inhibitor 65 tipranavir 65 olmesartan 65 formerly LymphoStat B 65 TYKERB 65 intranasal formulation 65 candesartan cilexetil 65 Sanofi Aventis Taxotere 65 Fodosine 65 Granulocyte Colony Stimulating Factor 65 Omacetaxine 65 histone deacetylase HDAC inhibitor 65 Ophena TM 65 Dacogen injection 65 Factor VIIa 65 severe hypersensitivity reactions 65 multiple myeloma MM 65 desvenlafaxine succinate 65 paclitaxel Taxol ® 65 Genentech Rituxan 65 albiglutide 65 pegylated interferons 65 FOLFOX6 65 BCG refractory 65 HuMax CD# 65 Octreolin 65 Adentri 65 AST ALT 65 fulvestrant 65 LHRH agonists 65 interleukin IL -# 65 Valdoxan 65 verteporfin 65 cabazitaxel 65 nalbuphine ER 65 Allovectin 7 65 fosbretabulin 65 Ecallantide 65 LEP ETU 65 HCD# [002] 65 IMA# 65 eltrombopag 65 DFMO 65 sunitinib Sutent ® 65 pemetrexed Alimta 65 r hGH 65 corticosteroid dexamethasone 65 FOLFOX6 chemotherapy regimen 65 weekly intravenous infusions 65 GW# [003] 65 thrombopoietin 65 Myelodysplastic Syndrome MDS 65 standard chemotherapy regimen 65 oral mTOR inhibitor 65 ULORIC 65 Glufosfamide 65 Laquinimod 65 NAbs 65 somatostatin analog 65 amrubicin 65 LEUKINE 65 Akt activation 65 Certolizumab pegol 65 myeloproliferative diseases 65 fosamprenavir 65 pharmacodynamic properties 65 alpha 2b 65 metastatic RCC 65 Pruvel 65 Saforis 65 denileukin diftitox 65 pan HDAC inhibitor 65 Interferon beta 65 Irinotecan 65 Elotuzumab 65 chronic eosinophilic leukemia 65 budesonide foam 65 HCV protease inhibitors 65 fluoropyrimidine 64 systemic ALCL 64 non nucleoside HCV 64 CDK inhibitor 64 small molecule tyrosine 64 HSP# inhibitor 64 severe oral mucositis 64 myopathy rhabdomyolysis 64 APTIVUS R 64 Kinoid 64 previously untreated follicular 64 phase IIb trial 64 celgosivir 64 Flu Cy 64 ovarian cancer chronic hepatitis 64 Known hypersensitivity 64 ® lenalidomide 64 EndoTAGTM 1 64 trastuzumab DM1 T DM1 64 non nucleoside inhibitor 64 TNF antagonist 64 FASLODEX 64 nucleotide analogue 64 PDE4 inhibitor 64 MNTX 64 GOUT 64 Alzhemed TM 64 voriconazole 64 Gleevec resistant 64 Topotecan 64 depsipeptide 64 targeted radiotherapeutic 64 SinuNase ™ 64 Panzem 64 stage IIIB 64 comparator arm 64 Pharmacokinetics PK 64 epirubicin 64 AKT inhibitor 64 DPP4 64 peg interferon 64 FOLPI 64 paricalcitol 64 oral methylnaltrexone 64 #I TM# 64 Noxafil 64 thalidomide dexamethasone 64 EGFR TKI 64 ACTEMRA TM 64 MPS IVA 64 endothelin receptor antagonists 64 cancer immunotherapies 64 enzastaurin 64 trabectedin 64 Vaprisol 64 cetuximab Erbitux 64 rhIGF-I/rhIGFBP-3 64 #D#C# 64 interferon therapy 64 pharmacokinetic interactions 64 HER2 positive metastatic breast 64 Dyloject TM 64 oxaliplatin Eloxatin 64 Pegylated interferon 64 CBLC# 64 nilotinib 64 Phase Ib study 64 beta interferons 64 leukotriene receptor antagonist 64 Zybrestat 64 Natalizumab 64 Cloretazine 64 Azedra 64 relapsing remitting MS RRMS 64 LY# [003] 64 FOLFOX chemotherapy 64 vinorelbine tartrate 64 TroVax ® 64 severe neutropenia 64 nab paclitaxel 64 mGluR2 NAM 64 Femara letrozole 64 PegIFN RBV 64 dosing cohort 64 oral FTY# 64 arbaclofen 64 atacicept 64 Phase 1a clinical 64 cytokine refractory 64 micafungin 64 VNP#M 64 paclitaxel Taxol R 64 pradefovir 64 Panzem NCD 64 intravenous immunoglobulin 64 intravenous bisphosphonates 64 oncolytic virus therapies 64 HER2 expression 64 Theratope 64 Neulasta ® 64 ritonavir boosted 64 FavId 64 CCR5 antagonist 64 Thalomid ® 64 5alpha reductase 64 advanced hepatocellular carcinoma 64 Trastuzumab 64 ularitide 64 glatiramer 64 Tovaxin TM 64 Triolex 64 gemcitabine cisplatin 64 Copegus ribavirin 64 goserelin 64 FluCide 64 clazosentan 64 beta2 agonist 64 Evoltra ® 64 letrozole Femara 64 lenalidomide Revlimid 64 hematologic toxicity 64 Allovectin 7 ® 64 oral picoplatin 64 irbesartan 64 Glypromate 64 Cimzia TM 64 XmAb# 64 ACAPODENE TM 64 Nexavar sorafenib 64 administered subcutaneously 64 eniluracil 64 crizotinib PF # 64 peginterferon alfa 2b 64 carboplatin paclitaxel 64 IAP inhibitor 64 Temsirolimus 64 TO AVOID PREGNANCY WHILE 64 huC# DM4 64 APOPTONE 64 colorectal cancer liver metastases 64 Rebif ® 64 including eniluracil ADH 64 dextromethorphan quinidine 64 Actilon 64 certolizumab 64 Capecitabine 64 nicardipine 64 phase IIa clinical 64 bevacizumab Avastin ® 64 fenretinide 64 aleglitazar 64 Fx #A 64 thymalfasin 64 DOXIL 64 Cloretazine R 64 CaPre TM 64 Peginterferon alfa 2b 64 favorable pharmacokinetic profile 64 clopidogrel Plavix 64 DermaVir Patch 64 ZACTIMA 64 ISTODAX 64 heavily pretreated patients 64 CA4P 64 histamine dihydrochloride 64 Fibrillex 64 dose cohort 64 vapreotide acetate 64 marketed pegylated interferons 64 dasatinib 64 maximally tolerated dose 64 epothilone 64 LymphoStat B TM 64 pediatric malignancies 64 aPTT 64 recurrent glioblastoma 64 omacetaxine mepesuccinate 64 CD3 monoclonal antibody 64 alpha 2a 64 registrational trial 64 postoperative chemotherapy 64 EXJADE 64 AVASTIN 64 Amrubicin 64 plasma kallikrein inhibitor 64 Bicifadine 64 lanreotide 64 dexrazoxane 64 treatment naive genotype 64 AZT zidovudine Retrovir 64 QTc prolongation 64 Folfox 64 TNF Tumor Necrosis Factor 64 AAG geldanamycin analog 64 dose escalation phase 64 Peg IFN 64 immunomodulation 64 R Saizen R 64 cancer neuroendocrine tumor 64 Interferon beta 1a 64 refractory NSCLC 64 PEGINTRON TM 64 5-fluorouracil/leucovorin 64 IFN α 64 tigecycline 64 nucleoside analogs 64 NV1FGF 64 Gleevec imatinib mesylate 64 Interferon beta 1b 64 Gemzar gemcitabine 64 relapsed MCL 64 Personalized Immunotherapy 64 myelodysplastic myeloproliferative diseases 64 polymerase inhibitor 64 rALLy trial 64 NATRECOR R 64 MIRCERA 64 HER2 overexpression 64 viral kinetics 64 RISPERDAL ® 64 amprenavir 64 Fludarabine 64 NAGS deficiency 64 bexarotene 64 Enzastaurin 64 opioid induced bowel dysfunction 64 anthracyclines taxanes 64 myelosuppression 64 volociximab 64 Hsp# inhibitors 64 vosaroxin 64 R lenalidomide 64 Prestara 64 oral rivaroxaban 64 metastatic renal cell carcinoma 64 sunitinib Sutent 64 elvitegravir 64 weekly subcutaneous injections 64 herpetic keratitis 64 maribavir 64 inhibitor RG# 64 RhuDex R 64 Phase IIb clinical trials 63 mitomycin 63 Vicriviroc 63 R roscovitine 63 IFN beta 63 castrate resistant prostate cancer 63 relapsed multiple myeloma 63 splenectomized patients 63 relapsed ovarian cancer 63 aplindore 63 Voreloxin 63 TRIOLEX 63 somatostatin analogues 63 MAXY alpha 63 azilsartan medoxomil 63 Leukine 63 gamma secretase inhibitor 63 cMET 63 zileuton 63 RhuDex 63 eosinophilic asthma 63 low dose cytarabine 63 pregabalin Lyrica 63 LHRH antagonists 63 inhaled iloprost 63 metastatic malignant melanoma 63 metaglidasen 63 tolevamer 63 phase IIb III 63 Sorafenib Nexavar 63 Hepsera adefovir dipivoxil 63 receptor monoclonal antibody 63 Mipomersen 63 Prosaptide 63 pharmacokinetic PK study 63 otelixizumab 63 LAF# 63 Entereg R 63 dexpramipexole 63 ancrod 63 SinuNase 63 BRIM2 63 KNS # 63 anthracycline chemotherapy 63 subcutaneous formulation 63 solithromycin 63 Amgen Neulasta ® 63 alkylating agents 63 CCX# 63 COPAXONE 63 abacavir lamivudine 63 teduglutide 63 ENMD # 63 TRO# 63 Canvaxin TM 63 post herpetic neuralgia PHN 63 fallopian tube cancers 63 ON #.Na 63 ponatinib 63 daunorubicin 63 Thiovir 63 selective agonist 63 investigational humanized monoclonal antibody 63 aldosterone antagonists 63 BIM #A# 63 rFIXFc 63 PROSTVAC VF 63 antiangiogenic agents 63 antiplatelet agent 63 OncoGel 63 Bonefos 63 cidofovir 63 VFEND 63 pharmacodynamic effects 63 tipranavir r 63 metastatic gastric 63 IMGN# 63 bicifadine 63 MyVax 63 immune modulator 63 regorafenib 63 PI3K/Akt pathway inhibitor 63 recurrent genital herpes 63 CB2 selective receptor agonist 63 neoadjuvant chemotherapy 63 R sorafenib tablets 63 achieved ACR# 63 refractory multiple myeloma 63 RSR# 63 Vectibix panitumumab 63 OncoVEX GM CSF 63 pegylated interferon alfa 63 HBeAg negative 63 TNF inhibitor 63 busulfan 63 8mg/kg 63 Alferon N 63 basiliximab 63 BMS # 63 tranylcypromine 63 Orally administered 63 Corgentin 63 Stedivaze 63 prucalopride 63 isoenzyme 63 intravenous dosing 63 personalized immunotherapy 63 sodium thiosulfate STS 63 Blinatumomab 63 piperacillin tazobactam 63 durable remissions 63 EndoTAG TM -1 63 dirucotide 63 ALK inhibitor 63 severe hypercholesterolemia 63 Tamibarotene 63 trastuzumab Herceptin 63 mTOR inhibitor 63 plus DOXIL 63 5-FU/LV 63 lipid lowering therapies 63 pegylated interferon alfa 2b 63 hA# 63 refractory CLL 63 bacillus Calmette Guerin 63 angiogenesis inhibitor 63 Ereska 63 p# biomarker 63 abacavir Ziagen 63 papillary renal cell carcinoma 63 Zavesca R 63 triciribine phosphate monohydrate 63 Elocalcitol 63 cyclophosphamide methotrexate 63 elvucitabine 63 R# #mg BID 63 WX UK1 63 XL# anticancer compounds 63 Subgroup analysis 63 catheter occlusion 63 genotypic resistance 63 sodium glucose cotransporter 63 MYDICAR 63 glatiramer acetate 63 allogeneic stem cell 63 Alinia 63 Intravenous immunoglobulin 63 Peginterferon alfa 2a 63 Dextofisopam 63 vaginally administered lidocaine 63 Hyphanox 63 radiotherapy RT 63 receptor antagonists 63 relapsed acute myelogenous 63 boosted protease inhibitor 63 Bosutinib 63 HQK 63 Cytoxan 63 saline placebo 63 reslizumab 63 hematologic abnormalities 63 dose dexamethasone 63 Allovectin 7 R 63 pediatric acute lymphoblastic 63 receptor blocker 63 efficacy endpoint 63 tegaserod 63 HIV coinfected 63 Bortezomib 63 acromegalic patients 63 mTOR inhibition 63 Campath alemtuzumab 63 Navelbine 63 Atrasentan 63 #mg/m# [002] 63 recurrent NSCLC 63 Pivotal Phase III 63 memantine Namenda 63 MyVax R 63 pharmacodynamic markers 63 amphotericin B 63 APTIVUS 63 vinca alkaloid 63 rFSH 63 DMAG 63 donepezil Aricept 63 plasma pharmacokinetics 63 chemotherapeutic drug 63 torsemide ER 63 sJIA 63 solanezumab 63 ALN HPN 63 ORENCIA ® 63 paclitaxel cisplatin 63 tumor necrosis 63 Azacitidine 63 olaparib 63 Navelbine ® 63 Vandetanib 63 indibulin 63 ATACAND 63 intravenous immunoglobulin IVIg 63 MT#/MEDI-# 63 Teysuno 63 Hydroxyurea 63 adrenal suppression 63 xanthine oxidase inhibitor 63 Xcytrin R 63 LCP Tacro TM 63 phase III isavuconazole 63 iclaprim 63 EGFR HER2 63 sunitinib 63 metastatic GIST 63 Vernakalant 63 FVIIa 63 BeneFIX 63 chemotherapy induced neutropenia 63 myelofibrosis polycythemia vera 63 PEG interferon 63 Exelixis compounds 63 Myelodysplastic syndromes MDS 63 anakinra 63 superficial bladder cancer 63 TG# [003] 63 non splenectomized 63 Phase Ib II 63 doxorubicin cyclophosphamide 63 biochemical relapse 63 methylnaltrexone bromide 63 dacarbazine 63 SNT-MC#/idebenone 63 antiangiogenic agent 63 MYDICAR ® 63 relapsed refractory 63 nutlin 3a 63 REMUNE R 63 nucleoside analogues 63 selective androgen receptor modulator 63 Fenretinide 63 pharmacologically active isomer 63 pegfilgrastim 63 chemoradiotherapy 63 Aurexis 63 sipuleucel T 63 TKI therapy 63 Insegia 63 IMiDs 63 tumor histology 63 pharmacodynamic PD 63 antiviral efficacy 63 Preclinical studies suggest 63 evaluating Actimmune 63 torsade de pointes 63 cell acute lymphoblastic 63 tremelimumab 63 GLP toxicology studies 63 sertraline Zoloft 63 treat chronic sinusitis 63 Forodesine HCl 63 fluvastatin 63 investigational protease inhibitor 63 torezolid 63 YERVOY 63 romidepsin novel 63 hypercholesterolemic patients 63 peginterferon alpha 2a 63 Contrave# 63 oral talactoferrin 63 PNH patients 63 Multiple Myeloma MM 63 Xeloda ® 63 Vacc 4x 63 mycophenolic acid 63 ocular formulation 63 mcg dose 63 CytoFabTM 63 immune modulating 63 Sutent sunitinib 63 dopamine partial agonist 63 deferiprone 63 secondary hyperparathyroidism 63 TMP SMX 63 oral ridaforolimus 63 Lu AA# 63 NOX E# 63 Glivec imatinib 63 Erlotinib 63 ganetespib 63 fluticasone salmeterol 63 MIRAPEX ER